大麻二醇:在患者中代谢和临床疗效
Giovanni Battista Dell'Isola1, Alberto Verrotti1, Miriam Sciaccaluga2,3
1Department of Pediatrics, University of Perugia, Perugia, Italy.
Expert opinion on drug metabolism & toxicology
|March 11, 2024
概括
大麻 (CBD) 显示出作为药物耐药性的有效治疗方法的希望. 本综述探讨了它的机制,临床试验,以及对脑病患者的益处.
科学领域:
- 药理学和神经科学 药理学和神经科学
- 大麻素治疗药物 大麻素治疗药物
背景情况:
- 治疗正在随着新的治疗药物而发展.
- Cannabidiol (CBD) 是一种非精神活性大麻化合物,已成为一个重要的发展.
- 纯化CBD配方Epidiolex是第一个由监管机构批准的大麻衍生药物.
研究的目的:
- 审查CBD作为抗发作药物的药理机制.
- 分析CBD在各种性脑病的临床试验.
- 提供关于CBD治疗耐药的综合指南.
主要方法:
- 现有文献的叙述性审查.
- 药理学数据的探索.
- 对中CBD临床试验结果的分析.
主要成果:
- CBD在控制发作方面表现出有效性.
- 研究强调了CBD的安全性和潜在的认知益处.
- CBD显示有望改善性脑病变患者的生活质量.
结论:
- 大麻是一种有前途的治疗选择,用于抗药性.
- 进一步的研究支持其被批准用于各种形式的.
- CBD提供了超出控制范围的潜在益处,特别是对于性脑病变.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296
Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Antiepileptic Drugs: Calcium Channel Blockers
393
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
393
Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Antiepileptic Drugs: Glutamate Antagonists
345
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
345


